Recent data indicate that cystic fibrosis (CF) airway mucus is anaerobic. This suggests that Pseudomonas aeruginosa infection in CF reflects biofilm formation and persistence in an anaerobic environment. P. aeruginosa formed robust anaerobic biofilms, the viability of which requires rhl quorum sensing and nitric oxide (NO) reductase to modulate or prevent accumulation of toxic NO, a byproduct of anaerobic respiration. Proteomic analyses identified an outer membrane protein, OprF, that was upregulated approximately 40-fold under anaerobic versus aerobic conditions. Further, OprF exists in CF mucus, and CF patients raise antisera to OprF. An oprF mutant formed poor anaerobic biofilms, due, in part, to defects in anaerobic respiration. Thus, f...
Concurrent to conventional bacterial pathogens, unusual microbes are emerging from cystic fibrosis (...
Concurrent to conventional bacterial pathogens, unusual microbes are emerging from cystic fibrosis (...
Cystic fibrosis (CF) patients typically suffer of persistent and recurrent lung infections caused by...
AbstractRecent data indicate that cystic fibrosis (CF) airway mucus is anaerobic. This suggests that...
AbstractRecent data indicate that cystic fibrosis (CF) airway mucus is anaerobic. This suggests that...
Recent evidence indicates that Pseudomonas aeruginosa residing as biofilms in airway mucus of cystic...
Pseudomonas aeruginosa, a gram-negative bacterium of clinical importance, forms more robust biofilm ...
The cystic fibrosis (CF) airway is characteristically colonized with a mucoid Pseudomonas aeruginosa...
© 2017 APMIS. Published by John Wiley & Sons Ltd In vitro studies of Pseudomonas aeruginosa and othe...
The cystic fibrosis (CF) airways have an incompletely characterized defect in innate defense that ev...
Pseudomonas aeruginosa is an important pathogen in cystic fibrosis (CF) chronically colonising most ...
poster abstractOne of the primary causes of high mortality in patients with Cystic Fibrosis (CF) is ...
Concurrently to conventional bacterial pathogens, unusual microbes are emerging from cystic fibrosis...
Pseudomonas aeruginosa, a gram-negative bacterium of clinical importance, forms more robust biofilm ...
A vexing problem in cystic fibrosis (CF) pathogenesis has been to explain the high prevalence of Pse...
Concurrent to conventional bacterial pathogens, unusual microbes are emerging from cystic fibrosis (...
Concurrent to conventional bacterial pathogens, unusual microbes are emerging from cystic fibrosis (...
Cystic fibrosis (CF) patients typically suffer of persistent and recurrent lung infections caused by...
AbstractRecent data indicate that cystic fibrosis (CF) airway mucus is anaerobic. This suggests that...
AbstractRecent data indicate that cystic fibrosis (CF) airway mucus is anaerobic. This suggests that...
Recent evidence indicates that Pseudomonas aeruginosa residing as biofilms in airway mucus of cystic...
Pseudomonas aeruginosa, a gram-negative bacterium of clinical importance, forms more robust biofilm ...
The cystic fibrosis (CF) airway is characteristically colonized with a mucoid Pseudomonas aeruginosa...
© 2017 APMIS. Published by John Wiley & Sons Ltd In vitro studies of Pseudomonas aeruginosa and othe...
The cystic fibrosis (CF) airways have an incompletely characterized defect in innate defense that ev...
Pseudomonas aeruginosa is an important pathogen in cystic fibrosis (CF) chronically colonising most ...
poster abstractOne of the primary causes of high mortality in patients with Cystic Fibrosis (CF) is ...
Concurrently to conventional bacterial pathogens, unusual microbes are emerging from cystic fibrosis...
Pseudomonas aeruginosa, a gram-negative bacterium of clinical importance, forms more robust biofilm ...
A vexing problem in cystic fibrosis (CF) pathogenesis has been to explain the high prevalence of Pse...
Concurrent to conventional bacterial pathogens, unusual microbes are emerging from cystic fibrosis (...
Concurrent to conventional bacterial pathogens, unusual microbes are emerging from cystic fibrosis (...
Cystic fibrosis (CF) patients typically suffer of persistent and recurrent lung infections caused by...